TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition

Citations Over TimeTop 25% of 2021 papers

Abstract

γ-secretase inhibitors (GSI) were developed to reduce the generation of Aβ peptide to find new Alzheimer's disease treatments. Clinical trials on Alzheimer's disease patients, however, showed several side effects that worsened the cognitive symptoms of the treated patients. The observed side effects were partially attributed to Notch signaling. However, the effect on other γ-secretase substrates, such as the p75 neurotrophin receptor (p75NTR) has not been studied in detail. p75NTR is highly expressed in the basal forebrain cholinergic neurons (BFCNs) during all life. Here, we show that GSI treatment induces the oligomerization of p75CTF leading to the cell death of BFCNs, and that this event is dependent on TrkA activity. The oligomerization of p75CTF requires an intact cholesterol recognition sequence (CRAC) and the constitutive binding of TRAF6, which activates the JNK and p38 pathways. Remarkably, TrkA rescues from cell death by a mechanism involving the endocytosis of p75CTF. These results suggest that the inhibition of γ-secretase activity in aged patients, where the expression of TrkA in the BFCNs is already reduced, could accelerate cholinergic dysfunction and promote neurodegeneration.

Related Papers

• → Nerve growth factor: structure and function(2001)199 cited
• → Specificity in Trk Receptor:Neurotrophin Interactions(2001)110 cited
• → The neuroprotective effect of NGF against glutamate neurotoxicity is mediated by P75 neurotrophin receptor in cortical cultures(1998)
• → The Mechanism of NGF Suggested by the NGF–TrkA-D5 Complex(2003)
• → Evaluation of microneurotrophins activity on neurotrophins receptors and their role in signalling, in in vitro an in vivo neurodegenerative conditions, such as alzheimer's disease(2023)